It's here! What a milestone!

Xenotransplantation is live!

Congrats Leonardo V. Riella so proud of you!

Check out the key takeaways from KDIGO #lupus nephritis guidelines 2024.
Do you agree with these graded recommendations, especially for voclosporin & belimumab?
Will this change your practice?
Join us at Nephrology Journal Club this week at
Tuesday 9 pm Feb 6 EDT
Wednesday 9 pm Feb 7 IST

#KidneyWk had tons of exciting advances in glomerular diseases. Because it is more than one can absorb in a limited time, we have gone through all GN-related talks, presentations, and abstracts and will share some highlights here over the next few weeks here 🧵👇

The GPS Scholarship is accepting applications!

The GlomCon Physician Scientist (GPS) Scholarship provides one year of support toward a clinical research project in glomerular diseases. For 2024, $250,000 is made available through eleven scholarships.

Learn more and apply here:

Rajnish Mehrotra Samir M. Parikh Swapnil Hiremath @[email protected] NIDDK GlomCon just announced an early career scholarship for clinical research in nephrology. Nothing to support a clinical trial but perhaps enough to buy some protected time for faculty, coordinator, or statistician. Hope all JASN_News and CJASN readers become aware of this

Reading this and pondering to myself:

The great ones rarely nail the timing of retirement. So many lose quality years before the dawn sets. Dr. P looks to have cracked it.

28 years of being the king of clinician educators, now cutting his cords like he practiced and taught -

#KidneyWk self-promotion 🤫

A GlomCon Real-World Evidence Study

The Natural History of Focal and Segmental Glomerulosclerosis (FSGS)

A large-scale, multi-center, RWE study of patients in diverse healthcare settings with a tissue diagnosis of FSGS

asn-online.org/education/kidn…

#KidneyWk pearls continues:

Sparsentan (SPAR) vs. Irbesartan (IRB) in Patients with Focal Segmental Glomerulosclerosis (FSGS): Results from the Phase 3 DUPLEX Trial

Presented by no one less than Michelle Rheault
Watch here
youtu.be/-q93K8lbk9Q?si…

One hour from now. Join us!

#onconephrology

What a great match! Such a privilege, can’t wait to meet everyone!

Join us! Open to all! Submit questions ahead of time!!! Raad Chowdhury, MD, FASN Harish Seethapathy

Join me as I geek out about Tubular Toxins!

Happening at 11 EST GlomCon

Management guidelines #ANCAVasculitis
Nicely depicted GlomCon by Kitching Laboratory on 9.11.23 ISN Education
📍ACR 2021
📍EULAR 2022
📍KDIGO 2021

🔥Severe Cases
⚡Induction - Rtx>CYC + Low dose GC
⚡PLEX-?Role
academic.oup.com/ndt/article/38…
Kate Robson Harish Seethapathy Sayna Norouzi, MD, FASN

⭐️⭐️⭐️ Today at the GlomCon fellowship program, we're fortunate to have the renowned Richard J. Glassock leading our session on lupus nephropathy.

#nephtwitter Don't worry if you're feeling a little jealous 😉😄

“Diagnosis” of the LN with biopsy!?

Kidney bx is basically not done for

🌟 Join our Glomerular Diseases Fellowship Hopkins Nephrology for July 2024 - June 2025! 🌟
🔬 Dive into rare diseases, research & patient care
📚 Comprehensive training in nephrology
🌎 ACGME residency & nephrology fellowship required
🌐 J1/H1B visas welcome
📄 Application details 👇

30 minutes in and Salem Almaani's engaged audience is ready to challenge him with a ton of questions on #Lupus Nephritis.

And yes, the talk GlomCon fellowship is as fantastic as expected!

I think we need to re-define ODS/CPM and involve our Neurology colleagues.

Considering the high % of CPM outside hypoNa settings, it's not reasonable to just focus on Na correction to mitigate this risk.

I am also not sure we fully und the implications of CPM/ODS. In recent

Ok #nephJC Nephrology Journal Club Let me get this off my chest so I can focus on the discussion.